Home > Healthcare > Medical Devices > Diagnostic Devices > Cuffless Blood Pressure Monitor Market

Cuffless Blood Pressure Monitor Market Share

  • Report ID: GMI6307
  • Published Date: Jul 2023
  • Report Format: PDF

Cuffless Blood Pressure Monitor Market Share

Some of the eminent market participants operating in the cuffless blood pressure monitor market include

  • Omron
  • CardiacSense
  • Valencell, Inc.
  • SOMNOmedics GmbH
  • Blumio
  • Biospectal
  • Aktiia
  • Equate Health
  • Fourth Frontier Technologies LLC
  • A&D Medical
  • Biobeat Technologies
  • Huawei Device Co., Ltd.

These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market for cuffless blood pressure monitor was valued at USD 585.7 million in 2022 and is estimated to account for USD 1.6 billion by 2032.

The wrist-based segment garnered USD 441.8 million revenue size in the year 2022, owing to the rising popularity among fitness enthusiasts, athletes, and those with hypertension due to its ability to assess physical activity and blood pressure in real time.

U.S. cuffless blood pressure monitor market accounted for USD 187.5 million in 2022 and is predicted to witness substantial market growth through 2032, on account of the increasing prevalence of hypertension in the region.

Omron, CardiacSense, Valencell, Inc., SOMNOmedics GmbH, Blumio, Biospectal, Aktiia, Equate Health, Fourth Frontier Technologies LLC, A&D Medical, Biobeat Technologies, Huawei Device Co., Ltd., among others.

Cuffless Blood Pressure Monitor Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 11
  • Tables & Figures: 267
  • Countries covered: 30
  • Pages: 180
 Download Free Sample